Literature DB >> 6242466

Regulation of B-cell growth and differentiation by soluble factors.

M Howard, W E Paul.   

Abstract

The B-lymphocyte family of cells presents one of the most remarkable opportunities for the detailed study of regulation of growth and differentiation. Some members of this cell population have the property that they may be stimulated by ligand-receptor interactions, together with the sequential action of a series of lymphokines, to progress from the resting state, through several rounds of proliferation, and then to differentiate to immunoglobulin secretion. Other cells in this group participate in cognate cellular interactions with helper T cells in which the recognition of both antigen and a class II MHC molecule on the B-cell surface is key to activation. The differentiation of these cells is also controlled by soluble products. We have reviewed our developing knowledge of the biochemistry and mode of action of the lymphokines that act upon B cells. These include distinct growth and differentiation factors. Among these are the BCGFs of mice and humans and the various TRFs, which include molecules often described as differentiation factors. The next several years should witness major progress in understanding the physicochemical properties of the B cell-specific factors, their time and nature of action, and the nature of their receptors. In addition, we can anticipate a major effort to understand the intracellular events that flow from the action of specific growth and differentiation factors that act upon B cells. Such information should lead to a new physiologically-based pharmacology for manipulation of antibody responses in human disease and in responses to vaccines. In addition, the fuller understanding of the nature and mode of action of the various growth and differentiation factors should make long-term growth of cloned B cells a procedure that can be routinely used in immunological laboratories for the precise study of the biology of responses by homogeneous populations of B lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6242466     DOI: 10.1146/annurev.iy.01.040183.001515

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  106 in total

1.  Targeting of T-B interaction using heteroconjugate antibody.

Authors:  J L Davignon; M Vallin-Davignon; P L Cohen; R A Eisenberg
Journal:  Immunology       Date:  1991-05       Impact factor: 7.397

2.  Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density.

Authors:  N Suzuki; Y Ueda; T Sakane
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Regulation of human B cell proliferation and differentiation by seminal plasma.

Authors:  H K Lee; H H Lee; Y M Park; J H Lee; T Y Ha
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

Review 4.  Role of ion channels in lymphocytes.

Authors:  B A Premack; P Gardner
Journal:  J Clin Immunol       Date:  1991-09       Impact factor: 8.317

5.  Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells.

Authors:  G G Klaus; C M Hawrylowicz; C J Carter
Journal:  Immunology       Date:  1985-07       Impact factor: 7.397

Review 6.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

7.  Dissociation of murine B-cell proliferation and differentiation by monoclonal antibody, NIM R2.

Authors:  S Marshall-Clarke; J Harrison; R M Parkhouse
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

8.  Naturally occurring mouse antibodies against T-cell-secreted chondroitin sulphate proteoglycan.

Authors:  D Levitt
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

9.  The B-cell activation pathway in human systemic lupus erythematosus: imbalanced in vitro production of lymphokines and association with serum analytical findings.

Authors:  M L Gaspar; M Alvarez-Mon; C Gutierrez
Journal:  J Clin Immunol       Date:  1988-07       Impact factor: 8.317

10.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.